797755-11-4

Basic information

• Product Name: 3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid
• Synonyms: 3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid;4-(2-Carboxyethyl)phenylboronic acid,pinacol ester
• CAS NO: 797755-11-4
• Molecular Formula: C₁₅H₂₁BO₄
• Molecular Weight: 276.14
• Mol File: 797755-11-4.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 410.9±28.0 °C(Predicted)
• Appearance: /
• Density: 1.11±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 4.63±0.10(Predicted)
• CAS DataBase Reference: 3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid(797755-11-4)
• EPA Substance Registry System: 3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid(797755-11-4)

Safety Data

• Hazardous Substances Data: 797755-11-4(Hazardous Substances Data)

Usage

Uses

4-(2-Carboxyethyl)phenylboronic acid, pinacol ester

Upstream product

• 76-09-5 2,3-dimethyl-2,3-butane diol 
• 2156-04-9 4-Vinylphenylboronic acid 
• 870004-04-9 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)styrene 
• 590-29-4 potassium formate 
• 3495-36-1 cesium formate 
• 1643-30-7 3-(4-bromophenyl)propionic acid 
• 73183-34-3 bis(pinacol)diborane 
• 166316-48-9 4-(2-carboxyethyl)benzeneboronic acid 
• 1643-29-4 3-(4-iodophenyl)propionic acid 

Relevant articles and documents

Photoredox Activation of Formate Salts: Hydrocarboxylation of Alkenes via Carboxyl Group Transfer

A photoredox activation mode of formate salts for carboxylation was developed. Using a formate salt as the reductant, carbonyl source, and hydrogen atom transfer reagent, a wide range of alkenes can be converted into acid products via a carboxyl group tra

PROTEIN TYROSINE PHOSPHATASE DEGRADERS AND METHODS OF USE THEREOF

Provided herein are compounds, compositions, and methods useful for degrading protein tyrosine phosphatase, e.g., protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases favorably responsive to PTPN1 or PTPN2 inhibitor treatment, e.g., a cancer 5 or a metabolic disease.

PQS-enabled visible-light iridium photoredox catalysis in water at room temperature

An amphoteric PQS-attached photocatalyst has been prepared that undergoes self-aggregation in water into nanomicelles. This covalently bound species enables Ir-based photoredox catalysis to be conducted in the absence of additives or co-solvents. Representative reactions are described using this new catalytic system, which require no additional investment of external energy in the form of heating or cooling. The entire aqueous reaction mixture readily undergoes in-flask recycling and thus, represents a sustainable precious metal technology.